News Search

The long-awaited discovery of the source of cells that contribute to pulmonary fibrosis could eventually lead to treatments that put a stop to the relentless disease.

Through a trial offered at Columbia, a patient who is ineligible for existing treatments is the first to receive an experimental gene therapy.

A multi-institutional team of researchers developed a tiny implantable microphone, paving the way for fully internal cochlear implants.